Friday, September 9, 2011

The medical device industry is unfettered by clinical trials, the justice system, etc.

(Link here ) New York Times editorial on damage from brain stents.

This will continue until the public demands that

  • patient/consumer stakeholders be given voting rights on the FDA medical device advisory panels
  • a web-published independent registry of all implant devices is established for transparency & academic study
  • the current pre-emption from state court is revoked for the device industry
  • no device is cleared by the FDA without a percentage of the life expectancy of the device being warranted.

No comments:

Post a Comment